Sign in
Taking peopleNo phase

Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder

Key facts

Who runs it
Centre Hospitalier Universitaire de Nīmes
Where
France7 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
168 people, planned
Started
20 Oct 2021
Expected to end
Jan 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Mindfulness Based Relapse Prevention
  • Relaxation/ meditation
Record updated
21 August 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Having a moderate to severe alcohol use disorder according to DSM 5 criteria
  • The last drink must have been consumed at most in the last 60 days before the pre-inclusion visit. The patient must have had at least 1 HDD during the last drinking period

Who cannot take part

  • Other mindfulness-based structured therapies
  • Schizophrenic disorder,
  • Patient with dementia or severe cognitive impairment that would prevent him/her from following the course of a session, as judged by the clinician
  • Severe depression (Beck Depression Inventory> 30)
  • Current maniac or hypomaniac episode,
  • Insufficient French understanding to complete the questionnaires
  • Pregnant or breastfeeding woman
  • Absence of social security regimen
  • Refusal to sign the written consent. • The patient is under safeguard of justice or state guardianship

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Alcohol use disorder (AUD) is the second highest preventable cause of death in France. Only 3% of patients are prescribed approved drugs for reducing alcohol consumption or maintenance of abstinence. Increasing evidence supports the efficacy of psychotherapies such as cognitive and behavioral therapies (CBT) in AUD. However, some patients are resistant to CBT and the positive effects of CBT could wane over time, resulting in mid- and long-term relapses. Mindfulness practice is increasingly widespread in the United States and its efficacy in various fields appears very promising. The study investigators hypothesize that the Mindfulness Based Relapse Prevention (MBRP) program will be more efficient than a relaxation/meditation without guidance control program in AUD.

The 2 groups in the trial

  • MBRP program:Treatment being tested

    Treatment: Mindfulness Based Relapse Prevention

  • Standard careExisting treatment, for comparison

    Treatment: Relaxation/ meditation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
21 August 2025